Free Trial
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

$8.79 +0.23 (+2.69%)
As of 07/8/2025 03:58 PM Eastern

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Key Stats

Today's Range
$8.59
$8.82
50-Day Range
$7.43
$8.79
52-Week Range
$6.80
$11.88
Volume
70,313 shs
Average Volume
62,080 shs
Market Capitalization
$46.50 million
Assets Under Management
$45.37 million
Dividend Yield
0.11%
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.58%0.56%0.52%0.56%
Total Expense0.50%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.50%0.60%0.63%0.63%0.60%
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

GNOM ETF News Headlines

10x Genomics Misses Revenue Forecast
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Global X Genomics & Biotechnology UCITS ETF (GNOM.L)
GNOM Global X Genomics & Biotechnology ETF
See More Headlines

GNOM ETF - Frequently Asked Questions

Global X Genomics & Biotechnology ETF's stock was trading at $9.71 at the start of the year. Since then, GNOM shares have decreased by 9.5% and is now trading at $8.79.

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Intel (INTC), Alibaba Group (BABA) and PayPal (PYPL).

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
51

Fund Statistics

Assets Under Management
$45.37 million
Average Daily Volume
$0.00
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
Optionable
Options Volume
1
Put Options
82
Call Options
1
Short Interest
37,000 shs

Miscellaneous

Beta
1.14
Creation Unit
50,000
Creation Fee
$500.00
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure


This page (NASDAQ:GNOM) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners